Clarivate Shares Fall After $600 Million Deal to Sell Life-Science, Healthcare Segment
By Grace YoonShares of Clarivate fell after the company said it was selling its life-science and healthcare segment to Altaris, a New York investment firm, for $600 million.The stock was down 4.8% to $2.47 in recent trading, and has fallen over 26% since the start of the year.Clarivate, a London-ba…